One telephone call triggered a new device that aims to give surgeons more precise diagnostic information about what to cut and what to preserve during cancer surgery.
Livia Schiavinato Eberlin, Ph.D., assistant professor of chemistry at The University of Texas (UT) at Austin, made that phone call, and James Suliburk, M.D., associate professor and head of endocrine surgery at Baylor College of Medicine, answered it.
“She wanted to test a mass spectrometer to see if it would rule in or rule out cancer,” Suliburk said. “I responded with ‘Yes!’”
Mass spectrometry is a fairly new application within clinical settings, Suliburk said. A mass spectrometer measures characteristics of individual molecules. Eberlin wanted to test the MasSpec Pen, a handheld device that can detect cancer by touch—in real time.
A surgeon holds the MasSpec Pen against the patient’s tissue and uses a foot pedal to trigger the automated analysis, waiting a few seconds for a result. The pen releases a drop of water onto the tissue, and small molecules from the tissue migrate into the water.
Then the device drives the water sample into the mass spectrometer, which reads thousands of molecules as a molecular fingerprint. When the MasSpec Pen completes the tissue analysis, the words “Normal” or “Cancer” appear automatically on a computer screen. Surgeons then know which tissue to remove and which tissue to leave in the body.
Significantly, the pen allows surgeons to analyze tissue while it’s still in the body, unlike frozen section analysis, the current method for diagnosing cancer during surgery and determining the boundary between cancerous tissue and healthy tissue.
The frozen section process, which has been around for 100 years, involves the removal of tissue or an organ so it can be studied under a microscope. Frozen section is often slow and sometimes inaccurate, and each sample can take a pathologist as much as 45 minutes to prepare and interpret, increasing the patient’s risk for infection.
In addition, frozen section analysis is difficult to interpret for some types of cancers. And once the tissue or organ is removed, it can’t be put back, said Suliburk, who often operates on the thyroid.
“We operate to remove a part of or all of the thyroid,” he said. “What we find is that a majority of the patients will not have cancer, but until now, our diagnostics were not to the point, yet, where we could improve that procedure.”
But with the MasSpec Pen, cancerous tissue is accurately identified in about 10 seconds, he said.
The MasSpec Pen was developed by a team of scientists, surgeons and James Suliburk, engineers from UT Austin, Baylor and The University of Texas MD Anderson Cancer Center.
Led by Eberlin, the team has demonstrated that the pen diagnoses cancer in live, tumor-bearing mice during surgery without causing any observable harm to the tissue or stress to the animals.
“We anticipate certain lesions will be 90 to 95 percent probable of a tissue diagnosis, but we want to give a more precise diagnosis,” Suliburk said. “Our goal is to be more than 95 percent accurate.”
The team is now refining the MasSpec Pen so it can read samples placed on microscope slides.
Suliburk expects to start testing the MasSpec Pen during oncologic surgeries this spring. The team hopes the U.S. Food and Drug Administration will approve the pen as a medical diagnostic.
“Dr. Eberlin and I both feel strongly that it will improve the care of the patient and revolutionize how we perform surgery,” Suliburk said. “Any time you can perform a more precise, safer surgery, it’s a win for the patients and results in better outcomes.”
These genes will never go out of style! Scientists are still looking at genes that were well studied in the Human Genome Project. https://t.co/cFHQ2rTwqg #genomes #genetics
Good Morning from #Aggieland! What wonderful way to start the day at the Texas A&M University Health Science Center. Photo taken by our very own Sam Craft.@TAMU #Aggies #Ags #TAMU #TAMHSC #AggieHealth #TAMUHealth #photography #sunrise #Texas @CityofBryan @CityofCS #bcstx https://t.co/4piTW1HklN
RT @UHCougarGameday: 🏈 | Are you attending the @UHCougarFB this Saturday night vs Texas Southern? See the Football Gameday parking map belo…
RT @UH_CDI: See you there!!! https://t.co/0XqbLxLjgt
RT @UHCougarFB: Back home on Saturday night. Join us at TDECU Stadium.#HTownTakeover vs. Texas Southern, presented by @CocaCola https://…
Up to 50% of cancer cases in the U.S. could be prevented with a healthy lifestyle. Try these 8 ways to lower your risk. #endcancer https://t.co/wNm2Ia3n8Y
Congratulations, Dr. Lewis! Thanks for all you do to support our mission to #endcancer. https://t.co/jpTainHPmu
Thank you to @TexasChildrens anesthesiologist Dr. Blaine Easley for presenting the @bcmhouston Anesthesiology Grand Rounds Lecture yesterday on Malignant Hyperthermia. #anesthesia #anesthesiology https://t.co/tUvo87LBKf
RT @TexasDSHS: In #Texas, approximately 1,700 children under age 20 are diagnosed with cancer and almost 200 children die annually. Know th…
RT @NOVAeducation: She drafted organ transplantation legislation at the @NIH and in 1990, she served as the US Surgeon General, the first w…
Depression Hard on Hearts https://t.co/y3aepJIfAi
RT @AndrewRouth: Robots are in the lab! Always exciting to get back from travels to find shiny new equipment in the lab. Thanks to a seed g…
Tomorrow, Friday, 9/21, we’ll host a #BidenCancerSummit, along with communities around the country. Join the conversation by watching the livestream of our discussion of ways to improve #cancer research, care prevention: https://t.co/i648448FQs #CancerMoonshot #endcancer https://t.co/NSmH5IKzPW
@ThePatrickWats1 @TAMUmedicine @TAMU @AmerMedicalAssn Great points @ThePatrickWats1! These are all challenges that women in any field face in the workplace. An inclusive, supportive environment is a place where all individuals can thrive.
RT @GlobalTB: #TBT to when we opened the #Tuberculosis Centre of Excellence in #ESwatini @bcmhouston Read more at https://t.co/OFcyU0x53J h…